Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Function and targeting of MALT1 paracaspase in cancer
Thomas J. O’Neill, Marie J. Tofaute, Daniel Krappmann
Cancer Treatment Reviews (2023) Vol. 117, pp. 102568-102568
Open Access | Times Cited: 19

Showing 19 citing articles:

Oncogene-induced MALT1 protease activity drives posttranscriptional gene expression in malignant lymphomas
Nicole Wimberger, Franziska Ober, Göksu Avar, et al.
Blood (2023) Vol. 142, Iss. 23, pp. 1985-2001
Open Access | Times Cited: 11
Single-cell transcriptomics identifies a dampened neutrophil function and accentuated T-cell cytotoxicity in tobacco flavored e-cigarette exposed mouse lungs
Gurvinder Kaur, Thomas Lamb, Ariel Tjitropranoto, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
MALT1 Inhibitors and Degraders: Strategies for NF-κB-Driven Malignancies
Ruyue Zhang, Zixuan Wang, Mengyuan Zhang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
QRICH1 mediates an intracellular checkpoint for CD8 + T cell activation via the CARD11 signalosome
Nicole Carter, Wihib D. Hankore, Yongkang Yang, et al.
Science Immunology (2025) Vol. 10, Iss. 105
Closed Access
Positive Prognostic Overall Survival Impacts of Methylated TGFB2 and MGMT in Adult Glioblastoma Patients
Sanjive Qazi, Michael Potts, Scott M. Myers, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1122-1122
Open Access
Single-cell transcriptomics identifies a dampened neutrophil function and accentuated T-cell cytotoxicity in tobacco flavored e-cigarette exposed mouse lungs
Gagandeep Kaur, Thomas Lamb, Ariel Tjitropranoto, et al.
(2025)
Open Access
Single-cell transcriptomics identifies a dampened neutrophil function and accentuated T-cell cytotoxicity in tobacco flavored e-cigarette exposed mouse lungs
Gagandeep Kaur, Thomas Lamb, Ariel Tjitropranoto, et al.
(2025)
Open Access
An updated patent review of MALT1 inhibitors (2021-present)
Matjaž Brvar, Thomas J. O’Neill, Oliver Plettenburg, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Unraveling the Impact of Six Pentacyclic Triterpenes Regulating Metabolic Pathways on Lung Carcinoma Cells
Anamaris Torres-Sanchez, Grace Torres, Sthephanie Estrada, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 694-694
Open Access | Times Cited: 3
MALT1 substrate cleavage: what is it good for?
Bahareh Nemati Moud, Franziska Ober, Thomas J. O’Neill, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
MALT1 protease inhibition restrains glioblastoma progression by reversing tumor-associated macrophage-dependent immunosuppression
Juliana H. Azambuja, Saigopalakrishna S. Yerneni, Lisa M. Maurer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Identification and molecular modelling of potential drugs targeting the genes involved in the progression of lung cancer in patients with idiopathic pulmonary fibrosis
Sanjukta Dasgupta
Gene Reports (2024), pp. 102067-102067
Closed Access | Times Cited: 1
Regulatory roles of CARD9-BCL10-Rac1 (CBR) signalome in islet β-cell function in health and metabolic stress: Is there room for MALT1?
Anjaneyulu Kowluru
Biochemical Pharmacology (2023) Vol. 218, pp. 115889-115889
Open Access | Times Cited: 2
The Inhibitors of Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 (MALT-1) Protease as Potential Treatment of ABC-DLBCL and Similar Diseases
Ahmed F. Abdel‐Magid
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 6, pp. 763-765
Open Access
Changes in mucosa‑associated lymphoid tissue 1 predicts therapeutic response and survival in patients with advanced melanoma receiving programmed cell death‑1 inhibitor monotherapy
Xiaoyan Miao, Ziyi Guo, Kai Zhang, et al.
Oncology Letters (2024) Vol. 28, Iss. 3
Open Access
Insights into mechanisms of MALT1 allostery from NMR and AlphaFold dynamic analyses
Johan Wallerstein, Xiao Han, Maria Levkovets, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access
Mucosa‑associated lymphoid tissue lymphoma translocation protein 1 inhibitor, MI‑2, attenuates non‑small cell lung cancer cell proliferation, migration and invasion, and promotes apoptosis by suppressing the JNK/c‑JUN pathway
Chunyan Wu, Wei Ge, Yun Wu
Oncology Letters (2024) Vol. 28, Iss. 4
Open Access
Blood MALT1 serves as a potential biomarker reflecting the response and survival of immune‑checkpoint‑inhibitor therapy in advanced hepatocellular carcinoma
Weiping Ma, Yachao Yue, Bing Dong, et al.
Oncology Letters (2024) Vol. 28, Iss. 4
Open Access
What’s brewing for MALT1 in lymphoma?
Marcel Spaargaren
Blood (2023) Vol. 142, Iss. 23, pp. 1939-1941
Open Access
Page 1

Scroll to top